|
⚲
|
| Keyboard |
| McGauley Thomas
✚
|
|
|---|---|
| CIK # | 0001550701 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001550701] | |
| 4 | [0001550701] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tenax Therapeutics Inc | |
| McGauley Thomas | |
| Galectin Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tenax Therapeutics Inc TENX
Stock Option (right to buy) · derivative
|
2026-01-30 | Option exercise | 50,000 | $0.00 | |
|
Tenax Therapeutics Inc TENX
Common Stock
|
2025-11-17 | Buy | 5,000 | $7.23 | 36,150 |
|
Tenax Therapeutics Inc TENX
Common Stock
|
2025-11-17 | Buy | 1,000 | $7.35 | 7,350 |
|
Tenax Therapeutics Inc TENX
Common Stock
|
2025-11-17 | Buy | 2,000 | $7.34 | 14,680 |
|
Galectin Therapeutics Inc GALT
Stock Option (Right to Buy) · derivative
|
2013-06-19 | Grant | 25,000 | $0.00 | |
|
Galectin Therapeutics Inc GALT
Common Stock
|
2012-05-24 | Buy | 10,000 | $2.35 | 23,500 |
|
Galectin Therapeutics Inc GALT
Stock Option (right to buy) · derivative
|
2012-05-23 | Grant | 10,000 | $0.00 |